Obesity Clinical Trial
— FFFOfficial title:
Fit For Delivery: A Study of the Effect of Exercise Intervention and Nutritional Counselling on Pregnancy Outcome.
NCT number | NCT01001689 |
Other study ID # | 811363 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2009 |
Est. completion date | September 2014 |
Verified date | December 2018 |
Source | Sorlandet Hospital HF |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
"Fit for Delivery" is a randomized, controlled study to examine the effects of an intervention during pregnancy which consists of exercise groups and nutritional counselling. The investigators will assess the outcomes of gestational weight gain, postpartum weight retention, large newborns, glucose regulation, and the incidence of complications of pregnancy and delivery such as gestational diabetes and Cesarean section.
Status | Completed |
Enrollment | 606 |
Est. completion date | September 2014 |
Est. primary completion date | August 2013 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Expecting first child - Gestational weeks 12-20 - Residence in one of the following towns: Kristiansand, Søgne, Sogndalen, Vennesla, Lillesand, Mandal Exclusion Criteria: - Twin or other multiple pregnancy - Preexisting diabetes - Physical handicap which precludes participation in exercise groups - Ongoing drug addiction - Serious mental disorder - BMI at or below 19 before pregnancy - Inability to read/write Norwegian or English |
Country | Name | City | State |
---|---|---|---|
Norway | Sorlandet Hospital | Kristiansand | Vest Agder |
Lead Sponsor | Collaborator |
---|---|
Sorlandet Hospital HF |
Norway,
Sagedal LR, Øverby NC, Bere E, Torstveit MK, Lohne-Seiler H, Småstuen M, Hillesund ER, Henriksen T, Vistad I. Lifestyle intervention to limit gestational weight gain: the Norwegian Fit for Delivery randomised controlled trial. BJOG. 2017 Jan;124(1):97-109. doi: 10.1111/1471-0528.13862. Epub 2016 Jan 14. — View Citation
Sagedal LR, Sanda B, Øverby NC, Bere E, Torstveit MK, Lohne-Seiler H, Hillesund ER, Pripp AH, Henriksen T, Vistad I. The effect of prenatal lifestyle intervention on weight retention 12 months postpartum: results of the Norwegian Fit for Delivery randomised controlled trial. BJOG. 2017 Jan;124(1):111-121. doi: 10.1111/1471-0528.13863. Epub 2016 Jan 20. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Maternal weight gain in pregnancy | weight gain in kg | Measured at the time of delivery | |
Primary | Weight of the newborn | weight in grams at delivery | Measured at the time of delivery | |
Primary | Maternal fasting serum glucose level | serum glucose | Measured at gestational week 30 | |
Primary | Incidence of operative delivery, both cesarean section and operative vaginal delivery | number of participants delivered by operative vaginal or cesarean section | Assessed following delivery | |
Primary | Maternal body composition | Measured using bioimpedance scale | Measured at 36 weeks of gestation | |
Secondary | Maternal weight retention | weight change in kg from pre-pregnancy weight | 12 months after delivery | |
Secondary | Measurement of serum levels of hormones which regulate serum glucose levels, in both the pregnant woman and her newborn baby. | insulin, leptin | Mother measured at gestational week 30, baby measured at delivery | |
Secondary | Incidence of women with serum glucose levels >7.8 mmol/l after 2 hour glucose challenge test | results of glucose challege test | Assessed at gestational week 30 | |
Secondary | Incidence of delivery complications | incidence of third and fourth degree tearing, hemmorhage | Assessed following delivery | |
Secondary | Proportion of newborns with birth weight over the 90th percentile for gestational age | weight at gestation, adjusted for population characteristics stratified by sex and gestational age | Assessed following delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |